Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN5 | P54829 | 4/20 | 0.36 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | ERN1 | O75460 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3452895 | 0.90 | KDM4E (0.33) | PTPN5PTPN2ERN1KDM4EMEN1 | |
| SCHEMBL3452783 | 0.88 | PTGDR2 (0.32) | PTPN5ESR1ESR2ERN1KDM4E | |
| SCHEMBL3452359 | 0.79 | ESR1 (0.42) | ESR1ESR2ERN1 | |
| SCHEMBL3452255 | 0.77 | ESR1 (0.41) | ESR1ESR2ERN1MEN1MAPT | |
| SCHEMBL12524314 | 0.76 | KDM4E (0.36) | PTPN5PTPN2ESR1ESR2KDM4E | |
| SCHEMBL3452569 | 0.76 | ESR1 (0.40) | PTPN5ESR1ESR2ERN1MAPT | |
| SCHEMBL3452572 | 0.75 | ESR1 (0.39) | PTPN5ESR1ESR2ERN1MEN1 | |
| SCHEMBL9655970 | 0.74 | KDM4E (0.42) | PTPN5PTPN2KDM4EMEN1MAPT | |
| SCHEMBL15625203 | 0.73 | ESR1 (0.41) | PTPN5PTPN2ESR1ESR2KDM4E | |
| SCHEMBL11629893 | 0.72 | ALOX15 (0.42) | PTPN5PTPN2ESR1ESR2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858819-B2 | Tris(formylphenyl) and novel polynuclear phenol derived therefrom | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20100099908-A1 | TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099908-A1 | TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM | AS3MT, RRM2, SHROOM3 | PTPN5 2155/4885PTPN2 1644/4885ESR1 132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.